Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,890
Total Claims
$7.5M
Drug Cost
2,260
Beneficiaries
$3,312
Cost/Patient
Risk Score Breakdown 5/100
Score components are additive. Read full methodology
Peer Comparison vs. 17,757 Ophthalmology providers
+452%
Cost per patient vs peers
$3,312 vs $600 avg
+99%
Brand preference vs peers
72.8% vs 36.7% avg
Brand vs Generic
Brand: 10,845 claims · $7.4M
Generic: 4,045 claims · $103K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lifitegrast | 2,889 | $2.9M |
| Cyclosporine | 1,769 | $2.7M |
| Bimatoprost | 1,439 | $681K |
| Varenicline Tartrate | 468 | $374K |
| Bromfenac Sodium | 686 | $250K |
| Brimonidine Tartrate/Timolol | 584 | $175K |
| Besifloxacin Hcl | 392 | $92K |
| Brimonidine Tartrate | 170 | $52K |
| Prednisolone Acetate | 1,527 | $46K |
| Dorzolamide Hcl/Timolol Maleat | 1,698 | $34K |
| Cyclosporine | 33 | $26K |
| Brinzolamide | 115 | $21K |
| Tobramycin/Dexamethasone | 64 | $18K |
| Difluprednate | 164 | $18K |
| Brinzolamide/Brimonidine Tart | 60 | $13K |
Prescribing Profile
23
Unique Drugs
5.0
Anomaly Score
Patient Profile
74
Avg Age
64%
Female
1.27
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About